TP53 and glioblastoma: Small molecules as inhibitors of intrinsic pathways are often used as therapeutic agents in glioma treatment [109,110], as the dysregulation of such pathways (e.g., signaling pathways involving RTKs, PI3K, p53, etc.)has a major role in GBM development [6].